These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27871021)

  • 61. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B.
    Kato J; Hasegawa K; Torii N; Yamauchi K; Hayashi N
    Hepatology; 1996 Mar; 23(3):389-95. PubMed ID: 8617416
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical characteristics and effect of secondary individualized therapy in chronic hepatitis B patients infected with the rtA181 mutation hepatitis B virus].
    Ji FZ; Wang L; Yang BH; Zhao JJ; Liu F; Xue Y; Li T
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):280-4. PubMed ID: 22964149
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vitro characterization of viral fitness of therapy-resistant hepatitis B variants.
    Villet S; Billioud G; Pichoud C; Lucifora J; Hantz O; Sureau C; Dény P; Zoulim F
    Gastroenterology; 2009 Jan; 136(1):168-176.e2. PubMed ID: 18996386
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
    Günther S; Paulij W; Meisel H; Will H
    Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The genetic backbone modulates the phenotype of hepatitis B surface antigen mutants.
    Beale MA; Ijaz S; Tedder RS
    J Gen Virol; 2010 Jan; 91(Pt 1):68-73. PubMed ID: 19759242
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype.
    Li W; Warner N; Sozzi V; Yuen L; Colledge D; Li T; Zhuang H; Locarnini S; Revill PA
    Hepatol Int; 2013 Jun; 7(2):443-50. PubMed ID: 26201776
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Naturally occurring hepatitis B virus (HBV) variants with primary resistance to antiviral therapy and S-mutants with potential primary resistance to adefovir in Argentina.
    Cuestas ML; Rivero CW; Minassian ML; Castillo AI; Gentile EA; Trinks J; León L; Daleoso G; Frider B; Lezama C; Galoppo M; Giacove G; Mathet VL; Oubiña JR
    Antiviral Res; 2010 Jul; 87(1):74-7. PubMed ID: 20403388
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection.
    Cassini R; De Mitri MS; Gibellini D; Urbinati L; Bagaglio S; Morsica G; Domenicali M; Verucchi G; Bernardi M
    J Viral Hepat; 2013 Jan; 20(1):42-9. PubMed ID: 23231083
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Biological characteristics of the A1762T/G1764A mutant strain of hepatitis B virus in vivo.
    Leng XH; Chen EQ; Du LY; Bai L; Gong DY; Cheng X; Huang FJ; Tang H
    Mol Med Rep; 2015 Oct; 12(4):5141-8. PubMed ID: 26165271
    [TBL] [Abstract][Full Text] [Related]  

  • 70. PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expression.
    Chu X; Wu B; Fan H; Hou J; Hao J; Hu J; Wang B; Liu G; Li C; Meng S
    Antiviral Res; 2016 Mar; 127():41-9. PubMed ID: 26784393
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment.
    Moriconi F; Colombatto P; Coco B; Ciccorossi P; Oliveri F; Flichman D; Maina AM; Sacco R; Bonino F; Brunetto MR
    J Antimicrob Chemother; 2007 Aug; 60(2):341-9. PubMed ID: 17567633
    [TBL] [Abstract][Full Text] [Related]  

  • 73. β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity.
    Hu Y; Cheng X; Cao F; Huang A; Tavis JE
    Antiviral Res; 2013 Sep; 99(3):221-9. PubMed ID: 23796982
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatocellular carcinoma and hepatitis B surface protein.
    Li YW; Yang FC; Lu HQ; Zhang JS
    World J Gastroenterol; 2016 Feb; 22(6):1943-52. PubMed ID: 26877602
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Specific expression of human interferon-gamma controls hepatitis B virus replication in vitro in secreting hepatitis B surface antigen hepatocytes.
    Kan Q; Li D; Yu Z
    J Virol Methods; 2012 Mar; 180(1-2):84-90. PubMed ID: 22240074
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants.
    Chowdhury A; Santra A; Chakravorty R; Banerji A; Pal S; Dhali GK; Datta S; Banerji S; Manna B; Chowdhury SR; Bhattacharya SK; Mazumder DG
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1712-20. PubMed ID: 16246191
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
    Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
    Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains.
    Amini-Bavil-Olyaee S; Herbers U; Luedde T; Trautwein C; Tacke F
    J Viral Hepat; 2011 Nov; 18(11):804-14. PubMed ID: 20887378
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Hepatitis B surface antigen terminates codon bias selection].
    Li JQ; Tian JH; Liu F; Du SC
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Jun; 40(3):270-2. PubMed ID: 18560454
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Surface gene mutations of hepatitis B virus among high-risk patients with occult hepatitis B virus infection.
    Hamkar R; Aghakhani A; Soufian S; Banifazl M; Ghavami N; Nadri M; Sofian M; Ahmadi F; Razeghi E; Eslamifar A; Ramezani A
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):285-91. PubMed ID: 19903586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.